Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Pharma & capital goods lead gains
Tue, 4 Jun 01:30 pm

Indian share markets pared gains in the post-noon trading session, but continued to trade above the dotted line. Majority of the sectoral indices are trading in the green with pharma, capital goods and auto stocks being the biggest gainers. Only consumer durable, metal and IT stocks are languishing in the red.

BSE-Sensex is up 60 points and NSE-Nifty is trading 19 points up. BSE Mid Cap is trading 0.4% up and BSE Small Cap index is trading up by 0.7%. The rupee is trading at 56.6 to the US dollar.

Mining stocks are trading mixed with MOIL and Gujarat NRE Coke being the biggest gainers and Coal India and Sesa Goa leading among losers. As per a leading financial daily, coal production of 34.5 m tonnes (MT) by Coal India Ltd (CIL) in May fell short of its target of 36.5 MT. Even its coal offtake at 38.2 MT was below its target of 40.9 MT. During the first two months of FY13, the company produced 70.3 MT of coal against its target of 71.6 MT. Last year, CIL's coal output was down by 12 MT from its projected production of 464 MT due to worker's strikes and other issues. The Coal Ministry has set a production target of 482 MT in FY13.

Most of the automobile stocks are trading are in green with Mahindra and Mahindra (M&M) and Tube investments being among the top gainers. As per a leading financial daily, domestic auto major M&M intends to launch six new tractor models in the current fiscal. Among these six new launches, one will be totally from a new platform, M Star. Reportedly, the company is working on this model since last two and half years. The remaining five will be variants of the existing models. As per the company CEO, Rajesh Jerurikar, the new platform generally requires an investment of around Rs 3.5 bn. The company has planned investment of upto Rs 100 bn during 2013-15 for capacity expansion and new product launches. The company's domestic sales of tractors grew by about 25%, with 22,471 units sold during May 2013, as compared to sale of 18,019 units in corresponding period previous year. M&M was trading up by 1.9%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Pharma & capital goods lead gains". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.